+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Artificial Intelligence in Pharmaceutical Market by Component (Hardware, Services, Software), Technology Type (Computer Vision, Machine Learning, Natural Language Processing), Applications, End User, Deployment Type - Global Forecast 2025-2030- Product Image
Artificial Intelligence in Pharmaceutical Market by Component (Hardware, Services, Software), Technology Type (Computer Vision, Machine Learning, Natural Language Processing), Applications, End User, Deployment Type - Global Forecast 2025-2030- Product Image
Sale

Artificial Intelligence in Pharmaceutical Market by Component (Hardware, Services, Software), Technology Type (Computer Vision, Machine Learning, Natural Language Processing), Applications, End User, Deployment Type - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 182 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5896366
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Senior decision-makers in the pharmaceutical sector face a rapidly evolving landscape. Artificial intelligence is reshaping how drugs are discovered, developed, and delivered, driving a new era of operational efficiency and scientific innovation.

Market Snapshot: Artificial Intelligence in Pharmaceutical Market

The Artificial Intelligence in Pharmaceutical Market grew from USD 15.79 billion in 2024 to USD 20.08 billion in 2025. It is expected to continue growing at a CAGR of 26.93%, reaching USD 66.08 billion by 2030. This significant expansion is underpinned by the integration of AI across the pharmaceutical value chain—from early-stage research to personalized patient care—making AI both a strategic imperative and a competitive differentiator in the industry.

Scope & Segmentation

This report thoroughly covers critical segments, applications, and geographies relevant to business and technology adoption in the Artificial Intelligence in Pharmaceutical Market.

  • Component: AI chipsets, graphic processing units, consulting services, managed services, deep learning frameworks, predictive analysis tools.
  • Technology Type: Computer vision, machine learning, natural language processing, robotic process automation.
  • Applications: Clinical trials, drug discovery, personalized healthcare, supply chain management, with sub-segments including patient recruitment, outcome forecasting, risk-based monitoring, drug design, biomarker discovery, and logistics optimization.
  • End User: Biotechnology companies, healthcare providers (clinics, hospitals, healthcare systems), pharmaceutical companies (big pharma, generic manufacturers, specialty pharmas), and research institutes (academic, industrial).
  • Deployment Type: Cloud-based, hybrid, on-premises environments.
  • Region: Americas (including United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (key countries include United Kingdom, Germany, France, Russia, UAE, Saudi Arabia, South Africa), and Asia-Pacific (notably China, India, Japan, Australia, South Korea, and Southeast Asian markets).
  • Market Participants: A diverse set of companies, ranging from AI-focused startups to established technology and pharmaceutical leaders such as AiCure, Atomwise, NVIDIA, Microsoft, International Business Machines Corporation, Exscientia, Insilico Medicine, Novo Nordisk, SANOFI WINTHROP INDUSTRIE, and others.

Key Takeaways for Senior Decision-Makers

  • AI is transforming pharmaceutical development from target identification through clinical delivery, accelerating cycle times and supporting precision-driven outcomes.
  • Widespread adoption of machine learning, natural language processing, and predictive analytics is facilitating risk mitigation and streamlining regulatory compliance, particularly as data requirements increase in complexity.
  • Strategic alliances—including partnerships between pharma, academia, and technology providers—are enabling faster scaling of generative AI solutions, empowering discovery and personalized medicine initiatives.
  • Regional differences are shaping technology uptake, with North America and Asia-Pacific leading advances via collaborative research networks, while highly regulated environments in Europe demand robust data governance and interoperability solutions.
  • Deployment models remain diversified: cloud-based solutions offer scalability and managed services, while hybrid and on-premises architectures are selected to address data security, compliance, and sovereignty requirements.
  • Market leadership increasingly depends on the capacity to embed AI in R&D workflows, deploy agile development approaches, and upskill internal teams to maximize AI’s impact on measurable clinical and commercial outcomes.

Tariff Impact on the U.S. Pharmaceutical Sector

Recent tariffs imposed on pharmaceutical imports and technology components in the United States have increased supply chain complexity and placed upward pressure on costs. Organizations are adjusting their sourcing approaches, including partial reshoring and reliance on domestic partners for critical AI hardware, while adapting to longer validation processes for new devices. Revisions to cross-border data sharing arrangements and development of regional research hubs are also strengthening operational resilience amid a fragmented global policy environment.

Methodology & Data Sources

The report’s findings are based on a rigorous combination of primary interviews with industry stakeholders—including executives, data scientists, and researchers—and secondary reviews of peer-reviewed publications, white papers, patent filings, and regulatory guidance. Extensive triangulation of proprietary databases and multi-source validation ensures reliable, actionable insights.

Why This Report Matters

  • Offers strategic guidance for technology planning, operational investment, and partnership formation aligned to real-time market dynamics in AI-driven pharmaceuticals.
  • Delivers granular segmentation and regional context to support data-driven decisions in resource allocation, risk management, and market prioritization.
  • Equips decision-makers with insights needed to anticipate regulatory changes, manage growing data complexity, and implement effective AI governance frameworks.

Conclusion

Artificial intelligence is setting new standards for efficiency and innovation across pharmaceutical R&D and patient care delivery. Leaders equipped with data, strategic insights, and robust partnerships will be best positioned to realize the potential of AI in the evolving global market.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Integration of generative AI for accelerated drug candidate structure optimization and synthesis planning
5.2. Application of federated learning frameworks for secure multi-center pharmaceutical data collaboration
5.3. Deployment of AI-driven digital twin models for personalized pharmacokinetic and dynamic simulations in trials
5.4. Development of explainable AI algorithms to ensure regulatory compliance in complex drug approval workflows
5.5. Adoption of deep learning models for high-throughput in silico screening of biologics targeting protein-protein interactions
5.6. Utilization of AI-guided robotic platforms for automated high-content cell-based assay development and analysis
5.7. Implementation of real-time AI-enabled pharmacovigilance systems leveraging social media and EHR data streams
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Artificial Intelligence in Pharmaceutical Market, by Component
8.1. Introduction
8.2. Hardware
8.2.1. AI Chipsets
8.2.2. Graphic Processing Units
8.3. Services
8.3.1. Consulting Services
8.3.2. Managed Services
8.4. Software
8.4.1. Deep Learning Frameworks
8.4.2. Predictive Analysis Tools
9. Artificial Intelligence in Pharmaceutical Market, by Technology Type
9.1. Introduction
9.2. Computer Vision
9.3. Machine Learning
9.4. Natural Language Processing
9.5. Robotic Process Automation
10. Artificial Intelligence in Pharmaceutical Market, by Applications
10.1. Introduction
10.2. Clinical Trials
10.2.1. Clinical Data Management
10.2.2. Patient Recruitment
10.2.3. Predictive Analytics
10.2.4. Risk-Based Monitoring
10.3. Drug Discovery
10.3.1. Drug Design
10.3.2. End-Model Validation
10.3.3. Lead Optimization
10.3.4. Target Selection
10.4. Personalized Healthcare
10.4.1. Biomarker Discovery
10.4.2. Genomic Profiling
10.4.3. Precision Medicine Development
10.5. Supply Chain Management
10.5.1. Demand Forecasting
10.5.2. Inventory Management
10.5.3. Logistics Optimization
11. Artificial Intelligence in Pharmaceutical Market, by End User
11.1. Introduction
11.2. Biotechnology Companies
11.2.1. Genetic Engineering
11.2.2. Therapeutics Development
11.3. Healthcare Providers
11.3.1. Clinics
11.3.2. Healthcare Systems
11.3.3. Hospitals
11.4. Pharmaceutical Companies
11.4.1. Big Pharma
11.4.2. Generic Drug Manufacturers
11.4.3. Specialty Pharmas
11.5. Research Institutes
11.5.1. Academic Research
11.5.2. Industrial Research
12. Artificial Intelligence in Pharmaceutical Market, by Deployment Type
12.1. Introduction
12.2. Cloud-Based
12.3. Hybrid
12.4. On-Premises
13. Americas Artificial Intelligence in Pharmaceutical Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Artificial Intelligence in Pharmaceutical Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Artificial Intelligence in Pharmaceutical Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. AiCure, LLC
16.3.2. Aspen Technology Inc.
16.3.3. Atomwise Inc.
16.3.4. BenevolentAI SA
16.3.5. BioSymetrics Inc.
16.3.6. BPGbio Inc.
16.3.7. Butterfly Network, Inc.
16.3.8. Cloud Pharmaceuticals, Inc.
16.3.9. Cyclica by Recursion Pharmaceuticals, Inc.
16.3.10. Deargen Inc.
16.3.11. Deep Genomics Incorporated
16.3.12. Deloitte Touche Tohmatsu Limited
16.3.13. Euretos Services BV
16.3.14. Exscientia PLC
16.3.15. Google LLC
16.3.16. Insilico Medicine
16.3.17. Intel Corporation
16.3.18. International Business Machines Corporation
16.3.19. InveniAI LLC
16.3.20. Isomorphic Labs Limited
16.3.21. Microsoft Corporation
16.3.22. Novo Nordisk A/S
16.3.23. NVIDIA Corporation
16.3.24. Oracle Corporation
16.3.25. SANOFI WINTHROP INDUSTRIE
16.3.26. Turbine Ltd.
16.3.27. Viseven Europe OU
16.3.28. XtalPi Inc.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY COMPONENT, 2024 VS 2030 (%)
FIGURE 6. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY COMPONENT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY TECHNOLOGY TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY TECHNOLOGY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY APPLICATIONS, 2024 VS 2030 (%)
FIGURE 10. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY APPLICATIONS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY DEPLOYMENT TYPE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY DEPLOYMENT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET: RESEARCHAI
FIGURE 26. ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET: RESEARCHSTATISTICS
FIGURE 27. ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET: RESEARCHCONTACTS
FIGURE 28. ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY HARDWARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY HARDWARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY AI CHIPSETS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY AI CHIPSETS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY GRAPHIC PROCESSING UNITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY GRAPHIC PROCESSING UNITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY HARDWARE, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY HARDWARE, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY CONSULTING SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY CONSULTING SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY MANAGED SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY MANAGED SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SOFTWARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY DEEP LEARNING FRAMEWORKS, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY DEEP LEARNING FRAMEWORKS, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY PREDICTIVE ANALYSIS TOOLS, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY PREDICTIVE ANALYSIS TOOLS, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SOFTWARE, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY COMPUTER VISION, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY COMPUTER VISION, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY MACHINE LEARNING, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY MACHINE LEARNING, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY NATURAL LANGUAGE PROCESSING, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY NATURAL LANGUAGE PROCESSING, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY ROBOTIC PROCESS AUTOMATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY ROBOTIC PROCESS AUTOMATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY APPLICATIONS, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY APPLICATIONS, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY CLINICAL TRIALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY CLINICAL TRIALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY CLINICAL DATA MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY CLINICAL DATA MANAGEMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY PATIENT RECRUITMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY PATIENT RECRUITMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY PREDICTIVE ANALYTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY PREDICTIVE ANALYTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY RISK-BASED MONITORING, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY RISK-BASED MONITORING, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY CLINICAL TRIALS, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY CLINICAL TRIALS, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY DRUG DESIGN, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY DRUG DESIGN, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY END-MODEL VALIDATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY END-MODEL VALIDATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY LEAD OPTIMIZATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY LEAD OPTIMIZATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY TARGET SELECTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY TARGET SELECTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY DRUG DISCOVERY, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY DRUG DISCOVERY, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY PERSONALIZED HEALTHCARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY PERSONALIZED HEALTHCARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY BIOMARKER DISCOVERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY BIOMARKER DISCOVERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY GENOMIC PROFILING, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY GENOMIC PROFILING, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY PRECISION MEDICINE DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY PRECISION MEDICINE DEVELOPMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY PERSONALIZED HEALTHCARE, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY PERSONALIZED HEALTHCARE, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SUPPLY CHAIN MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SUPPLY CHAIN MANAGEMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY DEMAND FORECASTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY DEMAND FORECASTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY INVENTORY MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY INVENTORY MANAGEMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY LOGISTICS OPTIMIZATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY LOGISTICS OPTIMIZATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SUPPLY CHAIN MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SUPPLY CHAIN MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY GENETIC ENGINEERING, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY GENETIC ENGINEERING, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY THERAPEUTICS DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY THERAPEUTICS DEVELOPMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY HEALTHCARE PROVIDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY HEALTHCARE PROVIDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY HEALTHCARE SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY HEALTHCARE SYSTEMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY HEALTHCARE PROVIDERS, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 113. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY BIG PHARMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 114. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY BIG PHARMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 115. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY GENERIC DRUG MANUFACTURERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 116. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY GENERIC DRUG MANUFACTURERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 117. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SPECIALTY PHARMAS, BY REGION, 2018-2024 (USD MILLION)
TABLE 118. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SPECIALTY PHARMAS, BY REGION, 2025-2030 (USD MILLION)
TABLE 119. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2024 (USD MILLION)
TABLE 120. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2025-2030 (USD MILLION)
TABLE 121. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 122. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 123. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY ACADEMIC RESEARCH, BY REGION, 2018-2024 (USD MILLION)
TABLE 124. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY ACADEMIC RESEARCH, BY REGION, 2025-2030 (USD MILLION)
TABLE 125. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY INDUSTRIAL RESEARCH, BY REGION, 2018-2024 (USD MILLION)
TABLE 126. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY INDUSTRIAL RESEARCH, BY REGION, 2025-2030 (USD MILLION)
TABLE 127. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 128. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 129. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY DEPLOYMENT TYPE, 2018-2024 (USD MILLION)
TABLE 130. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY DEPLOYMENT TYPE, 2025-2030 (USD MILLION)
TABLE 131. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY CLOUD-BASED, BY REGION, 2018-2024 (USD MILLION)
TABLE 132. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY CLOUD-BASED, BY REGION, 2025-2030 (USD MILLION)
TABLE 133. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY HYBRID, BY REGION, 2018-2024 (USD MILLION)
TABLE 134. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY HYBRID, BY REGION, 2025-2030 (USD MILLION)
TABLE 135. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY ON-PREMISES, BY REGION, 2018-2024 (USD MILLION)
TABLE 136. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY ON-PREMISES, BY REGION, 2025-2030 (USD MILLION)
TABLE 137. AMERICAS ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 138. AMERICAS ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 139. AMERICAS ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY HARDWARE, 2018-2024 (USD MILLION)
TABLE 140. AMERICAS ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY HARDWARE, 2025-2030 (USD MILLION)
TABLE 141. AMERICAS ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 142. AMERICAS ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 143. AMERICAS ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
TABLE 144. AMERICAS ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SOFTWARE, 2025-2030 (USD MILLION)
TABLE 145. AMERICAS ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 146. AMERICAS ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 147. AMERICAS ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY APPLICATIONS, 2018-2024 (USD MILLION)
TABLE 148. AMERICAS ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY APPLICATIONS, 2025-2030 (USD MILLION)
TABLE 149. AMERICAS ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY CLINICAL TRIALS, 2018-2024 (USD MILLION)
TABLE 150. AMERICAS ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY CLINICAL TRIALS, 2025-2030 (USD MILLION)
TABLE 151. AMERICAS ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY DRUG DISCOVERY, 2018-2024 (USD MILLION)
TABLE 152. AMERICAS ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY DRUG DISCOVERY, 2025-2030 (USD MILLION)
TABLE 153. AMERICAS ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY PERSONALIZED HEALTHCARE, 2018-2024 (USD MILLION)
TABLE 154. AMERICAS ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY PERSONALIZED HEALTHCARE, 2025-2030 (USD MILLION)
TABLE 155. AMERICAS ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SUPPLY CHAIN MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 156. AMERICAS ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SUPPLY CHAIN MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 157. AMERICAS ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 158. AMERICAS ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 159. AMERICAS ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2024 (USD MILLION)
TABLE 160. AMERICAS ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2025-2030 (USD MILLION)
TABLE 161. AMERICAS ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2024 (USD MILLION)
TABLE 162. AMERICAS ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY HEALTHCARE PROVIDERS, 2025-2030 (USD MILLION)
TABLE 163. AMERICAS ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2024 (USD MILLION)
TABLE 164. AMERICAS ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2025-2030 (USD MILLION)
TABLE 165. AMERICAS ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 166. AMERICAS ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 167. AMERICAS ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY DEPLOYMENT TYPE, 2018-2024 (USD MILLION)
TABLE 168. AMERICAS ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY DEPLOYMENT TYPE, 2025-2030 (USD MILLION)
TABLE 169. AMERICAS ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 170. AMERICAS ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 171. UNITED STATES ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 172. UNITED STATES ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 173. UNITED STATES ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY HARDWARE, 2018-2024 (USD MILLION)
TABLE 174. UNITED STATES ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY HARDWARE, 2025-2030 (USD MILLION)
TABLE 175. UNITED STATES ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 176. UNITED STATES ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 177. UNITED STATES ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
TABLE 178. UNITED STATES ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SOFTWARE, 2025-2030 (USD MILLION)
TABLE 179. UNITED STATES ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 180. UNITED STATES ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 181. UNITED STATES ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY APPLICATIONS, 2018-2024 (USD MILLION)
TABLE 182. UNITED STATES ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY APPLICATIONS, 2025-2030 (USD MILLION)
TABLE 183. UNITED STATES ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY CLINICAL TRIALS, 2018-2024 (USD MILLION)
TABLE 184. UNITED STATES ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY CLINICAL TRIALS, 2025-2030 (USD MILLION)
TABLE 185. UNITED STATES ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY DRUG DISCOVERY, 2018-2024 (USD MILLION)
TABLE 186. UNITED STATES ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY DRUG DISCOVERY, 2025-2030 (USD MILLION)
TABLE 187. UNITED STATES ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY PERSONALIZED HEALTHCARE, 2018-2024 (USD MILLION)
TABLE 188. UNITED STATES ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY PERSONALIZED HEALTHCARE, 2025-2030 (USD MILLION)
TABLE 189. UNITED STATES ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SUPPLY CHAIN MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 190. UNITED STATES ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SUPPLY CHAIN MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 191. UNITED STATES ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 192. UNITED STATES ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 193. UNITED STATES ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2024 (USD MILLION)
TABLE 194. UNITED STATES ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2025-2030 (USD MILLION)
TABLE 195. UNITED STATES ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2024 (USD MILLION)
TABLE 196. UNITED STATES ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY HEALTHCARE PROVIDERS, 2025-2030 (USD MILLION)
TABLE 197. UNITED STATES ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2024 (USD MILLION)
TABLE 198. UNITED STATES ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2025-2030 (USD MILLION)
TABLE 199. UNITED STATES ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 200. UNITED STATES ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 201. UNITED STATES ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY DEPLOYMENT TYPE, 2018-2024 (USD MILLION)
TABLE 202. UNITED STATES ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY DEPLOYMENT TYPE, 2025-2030 (USD MILLION)
TABLE 203. UNITED STATES ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 204. UNITED STATES ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 205. CANADA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 206. CANADA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 207. CANADA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY HARDWARE, 2018-2024 (USD MILLION)
TABLE 208. CANADA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY HARDWARE, 2025-2030 (USD MILLION)
TABLE 209. CANADA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 210. CANADA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 211. CANADA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
TABLE 212. CANADA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SOFTWARE, 2025-2030 (USD MILLION)
TABLE 213. CANADA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 214. CANADA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 215. CANADA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY APPLICATIONS, 2018-2024 (USD MILLION)
TABLE 216. CANADA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY APPLICATIONS, 2025-2030 (USD MILLION)
TABLE 217. CANADA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY CLINICAL TRIALS, 2018-2024 (USD MILLION)
TABLE 218. CANADA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY CLINICAL TRIALS, 2025-2030 (USD MILLION)
TABLE 219. CANADA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY DRUG DISCOVERY, 2018-2024 (USD MILLION)
TABLE 220. CANADA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY DRUG DISCOVERY, 2025-2030 (USD MILLION)
TABLE 221. CANADA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY PERSONALIZED HEALTHCARE, 2018-2024 (USD MILLION)
TABLE 222. CANADA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY PERSONALIZED HEALTHCARE, 2025-2030 (USD MILLION)
TABLE 223. CANADA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SUPPLY CHAIN MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 224. CANADA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SUPPLY CHAIN MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 225. CANADA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 226. CANADA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 227. CANADA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2024 (USD MILLION)
TABLE 228. CANADA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2025-2030 (USD MILLION)
TABLE 229. CANADA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2024 (USD MILLION)
TABLE 230. CANADA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY HEALTHCARE PROVIDERS, 2025-2030 (USD MILLION)
TABLE 231. CANADA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2024 (USD MILLION)
TABLE 232. CANADA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2025-2030 (USD MILLION)
TABLE 233. CANADA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 234. CANADA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 235. CANADA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY DEPLOYMENT TYPE, 2018-2024 (USD MILLION)
TABLE 236. CANADA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY DEPLOYMENT TYPE, 2025-2030 (USD MILLION)
TABLE 237. MEXICO ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 238. MEXICO ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 239. MEXICO ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY HARDWARE, 2018-2024 (USD MILLION)
TABLE 240. MEXICO ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY HARDWARE, 2025-2030 (USD MILLION)
TABLE 241. MEXICO ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 242. MEXICO ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 243. MEXICO ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
TABLE 244. MEXICO ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SOFTWARE, 2025-2030 (USD MILLION)
TABLE 245. MEXICO ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 246. MEXICO ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 247. MEXICO ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY APPLICATIONS, 2018-2024 (USD MILLION)
TABLE 248. MEXICO ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY APPLICATIONS, 2025-2030 (USD MILLION)
TABLE 249. MEXICO ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY CLINICAL TRIALS, 2018-2024 (USD MILLION)
TABLE 250. MEXICO ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY CLINICAL TRIALS, 2025-2030 (USD MILLION)
TABLE 251. MEXICO ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY DRUG DISCOVERY, 2018-2024 (USD MILLION)
TABLE 252. MEXICO ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY DRUG DISCOVERY, 2025-2030 (USD MILLION)
TABLE 253. MEXICO ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY PERSONALIZED HEALTHCARE, 2018-2024 (USD MILLION)
TABLE 254. MEXICO ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY PERSONALIZED HEALTHCARE, 2025-2030 (USD MILLION)
TABLE 255. MEXICO ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SUPPLY CHAIN MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 256. MEXICO ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SUPPLY CHAIN MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 257. MEXICO ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 258. MEXICO ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 259. MEXICO ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2024 (USD MILLION)
TABLE 260. MEXICO ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2025-2030 (USD MILLION)
TABLE 261. MEXICO ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2024 (USD MILLION)
TABLE 262. MEXICO ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY HEALTHCARE PROVIDERS, 2025-2030 (USD MILLION)
TABLE 263. MEXICO ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2024 (USD MILLION)
TABLE 264. MEXICO ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2025-2030 (USD MILLION)
TABLE 265. MEXICO ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 266. MEXICO ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 267. MEXICO ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY DEPLOYMENT TYPE, 2018-2024 (USD MILLION)
TABLE 268. MEXICO ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY DEPLOYMENT TYPE, 2025-2030 (USD MILLION)
TABLE 269. BRAZIL ARTIFICIAL INTELLIGENCE IN P

Samples

Loading
LOADING...

Companies Mentioned

The major companies profiled in this Artificial Intelligence in Pharmaceutical market report include:
  • AiCure, LLC
  • Aspen Technology Inc.
  • Atomwise Inc.
  • BenevolentAI SA
  • BioSymetrics Inc.
  • BPGbio Inc.
  • Butterfly Network, Inc.
  • Cloud Pharmaceuticals, Inc.
  • Cyclica by Recursion Pharmaceuticals, Inc.
  • Deargen Inc.
  • Deep Genomics Incorporated
  • Deloitte Touche Tohmatsu Limited
  • Euretos Services BV
  • Exscientia PLC
  • Google LLC
  • Insilico Medicine
  • Intel Corporation
  • International Business Machines Corporation
  • InveniAI LLC
  • Isomorphic Labs Limited
  • Microsoft Corporation
  • Novo Nordisk A/S
  • NVIDIA Corporation
  • Oracle Corporation
  • SANOFI WINTHROP INDUSTRIE
  • Turbine Ltd.
  • Viseven Europe OU
  • XtalPi Inc.

Table Information

Report AttributeDetails
No. of Pages182
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 20.08 Billion
Forecasted Market Value ( USD ) by 2030 $ 66.08 Billion
Compound Annual Growth Rate26.9%
Regions CoveredGlobal
No. of Companies Mentioned28

Related Topics

Related Reports

Artificial Intelligence Market Global Report by Solution, Technology, End-User, Countries and Company Analysis 2025-2033 - Product Image

Artificial Intelligence Market Global Report by Solution, Technology, End-User, Countries and Company Analysis 2025-2033

  • Report
  • 250 Pages
  • Global
From
United States Artificial Intelligence Market Report and Forecast 2025-2034 - Product Image

United States Artificial Intelligence Market Report and Forecast 2025-2034

  • Report
  • 135 Pages
  • United States
From
North America Artificial Intelligence Market, By Country, Competition, Forecast, and Opportunities, 2019-2029F - Product Image

North America Artificial Intelligence Market, By Country, Competition, Forecast, and Opportunities, 2019-2029F

  • Report
  • 132 Pages
  • North America
From
Artificial Intelligence (AI) and the Metaverse: Intellectual Property (IP) and Standards and Policies Training Course (November 11, 2025) - Product Image

Artificial Intelligence (AI) and the Metaverse: Intellectual Property (IP) and Standards and Policies Training Course (November 11, 2025)

  • Training
  • 1 Day
  • Global
Artificial Intelligence in Biomedical Market by Component (Hardware, Services, Software), Technology (Computer Vision, Machine Learning, Natural Language Processing), Business Function, Application, End User, Deployment Mode - Global Forecast 2025-2030 - Product Image

Artificial Intelligence in Biomedical Market by Component (Hardware, Services, Software), Technology (Computer Vision, Machine Learning, Natural Language Processing), Business Function, Application, End User, Deployment Mode - Global Forecast 2025-2030

  • Report
  • 196 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.